Loading…

TCT-819 Prediabetes and its Impact on 1-Year Clinical Outcome After Treatment with Newer-Generation Drug-eluting Stents in 2,986 All-Comer Patients

Yet it is unclear whether detection of Pre-DM by routine assessment of glycated haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) among patients undergoing percutaneous coronary intervention (PCI) may help identify subjects with increased event risk. In non-DM patients who require stenting fo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B333-B333
Main Authors: Kok, Marlies, Von Birgelen, Clemens, Zocca, Paolo, Lowik, Marije, Danse, Peter, Schotborgh, Carl, Scholte, Martijn, Hartmann, Marc, Doelman, Cees, Kant, Gert, Tjon Joe Gin, R. Melvyn, Stoel, Martin, Gert van Houwelingen, K., Linssen, Gerard C.M., Doggen, Carine J.M., van der Heijden, Liefke
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Yet it is unclear whether detection of Pre-DM by routine assessment of glycated haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) among patients undergoing percutaneous coronary intervention (PCI) may help identify subjects with increased event risk. In non-DM patients who require stenting for obstructive coronary disease, routine assessment of HbA1c and FPG appears be of clinical value to identify subjects with increased event risk.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.1029